211 related articles for article (PubMed ID: 27276876)
1. Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy.
Seibold J; Strnad V; Fietkau R
Strahlenther Onkol; 2016 Jul; 192(7):467-72. PubMed ID: 27276876
[TBL] [Abstract][Full Text] [Related]
2. Penile brachytherapy: results for 49 patients.
Crook JM; Jezioranski J; Grimard L; Esche B; Pond G
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):460-7. PubMed ID: 15890588
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term results.
Sharma DN; Joshi NP; Gandhi AK; Haresh KP; Gupta S; Julka PK; Rath GK
Brachytherapy; 2014; 13(5):481-7. PubMed ID: 25037912
[TBL] [Abstract][Full Text] [Related]
4. Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Wojcieszek P; Szlag M; Cholewka A; Wesołowski M; Ślęczka M; Krzysztofiak T; Larysz D; Kołosza Z; Trzaska K; Pruefer A
Brachytherapy; 2019; 18(4):493-502. PubMed ID: 31101437
[TBL] [Abstract][Full Text] [Related]
5. Penile brachytherapy-Retrospective review of a single institution.
Pimenta A; Gutierrez C; Mosquera D; Pera J; Martínez E; Londres B; Pino F; Moreno S; Garcia M; Guedea F
Brachytherapy; 2015; 14(4):525-30. PubMed ID: 25863414
[TBL] [Abstract][Full Text] [Related]
6. Clinical Experience with Pulse Dose Rate Brachytherapy for Conservative Treatment of Penile Carcinoma and Comparison with Historical Data of Low Dose Rate Brachytherapy.
Kamsu-Kom L; Bidault F; Mazeron R; Baratiny C; Martin V; Maroun P; Dumas I; Guemnie-Tafo A; Martinetti F; Gerbaulet A; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):387-93. PubMed ID: 26003455
[TBL] [Abstract][Full Text] [Related]
7. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).
Cordoba A; Escande A; Lopez S; Mortier L; Mirabel X; Coche-Déqueant B; Lartigau E
Radiat Oncol; 2016 Jul; 11():96. PubMed ID: 27464910
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy for conservative treatment of invasive penile carcinoma in older patients: Single institution experience.
Escande A; Maroun P; Dumas I; Schernberg A; Bossi A; De Crevoisier R; Deutsch E; Haie-Meder C; Chargari C
J Geriatr Oncol; 2018 May; 9(3):275-278. PubMed ID: 29170049
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique.
Marbán M; Crook J; Keyes M; Dubash R; Batchelar D
Brachytherapy; 2020; 19(2):201-209. PubMed ID: 31959520
[TBL] [Abstract][Full Text] [Related]
10. Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma.
Gambachidze D; Lebacle C; Maroun P; Escande A; Bossi A; Blanchard P; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2018; 17(1):221-226. PubMed ID: 29089276
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
[TBL] [Abstract][Full Text] [Related]
12. Principles and practice of high-dose rate penile brachytherapy: Planning and delivery techniques.
Parsai S; Cherian S; Berglund RK; Lee B; Kolar M; Nagle-Hernan N; Wilkinson A; Ciezki J
Pract Radiat Oncol; 2018; 8(6):e386-e391. PubMed ID: 29890234
[TBL] [Abstract][Full Text] [Related]
13. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
14. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men agedGómez-Iturriaga Piña A; Crook J; Borg J; Lockwood G; Fleshner N
Urology; 2010 Jun; 75(6):1412-6. PubMed ID: 20035986
[TBL] [Abstract][Full Text] [Related]
15. Interstitial brachytherapy for penile cancer: an alternative to amputation.
Crook J; Grimard L; Tsihlias J; Morash C; Panzarella T
J Urol; 2002 Feb; 167(2 Pt 1):506-11. PubMed ID: 11792907
[TBL] [Abstract][Full Text] [Related]
16. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
Solan AN; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
[TBL] [Abstract][Full Text] [Related]
17. Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis.
Zilli T; Taussky D; Donath D; Le HP; Larouche RX; Béliveau-Nadeau D; Hervieux Y; Delouya G
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e377-83. PubMed ID: 21514068
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate interstitial brachytherapy for the treatment of penile carcinoma.
Petera J; Odrázka K; Zouhar M; Bedrosová J; Dolezel M
Strahlenther Onkol; 2004 Feb; 180(2):123-5. PubMed ID: 14762666
[TBL] [Abstract][Full Text] [Related]
19. Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome.
Escande A; Haie-Meder C; Mazeron R; Maroun P; Cavalcanti A; de Crevoisier R; Schernberg A; Marsolat F; Blanchard P; Martinetti F; Bossi A; Dumas I; Deutsch E; Chargari C
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):563-570. PubMed ID: 28501419
[TBL] [Abstract][Full Text] [Related]
20. Brachytherapy for penile cancer using silicon mold.
Akimoto T; Mitsuhashi N; Takahashi I; Yonome I; Takahashi M; Hayakawa K; Niibe H
Oncology; 1997; 54(1):23-7. PubMed ID: 8978588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
